Mdr-1 And Gst Polymorphisms Are Involved In Myelodysplasia Progression

Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal stem cell disorders characterized by abnormal hematopoietic differentiation and maturation, which progress toward acute leukemia in approximately 30% of the cases. Drug metabolism polymorphisms in Cytochrome P450 2B6 (CYP2B6), Glutathione S-transferase (GST) and Dehydrogenase Quinone 1 (NQO1) enzymes and P-glycoprotein (MDR-1) could modify enzyme activity. Thus, the aim of this study was to identify the influence of CYP2B6 G15631T, GSTT1, GSTM1, NQO1 C609T and MDR-1 C3435T polymorphisms on MDS progression. We analyzed 78 MDS patients using the PCR-RFLP and multiplex method. The frequency of GST deletions and MDR-1 CC genotype was lower in progression-free patients compared to patients with progression; GST: 17% vs. 35% (P=0.018); MDR-1 gene: 19% vs. 48% (P=0.012). We also verified the influence of GST deletions and MDR-1 C3435T on patient overall survival and found no significant difference (RR=0.75; P=0.599 and RR=0.79; P=0.594 respectively). We concluded that GSTM1 deletion may contribute toward MDS progression probably due to toxic metabolite accumulation which generates cell toxicity and DNA damage. Moreover, MDR-1 C3435T may have a protective effect against MDS progression because the expected lower expression of P-glycoprotein would lead to a higher degree of cell death. To the best of our knowledge, this is the first study showing the relationship of these polymorphisms with MDS progression. © 2013 Elsevier Ltd.378970973Vardiman, J.W., Harris, N.L., Brunning, R.D., The World Health Organization (WHO) classification of the myeloid neoplasms (2002) Blood, 100, pp. 2292-2302Nolte, F., Hofmann, W.K., Myelodysplastic syndromes: molecular pathogenesis and genomic changes (2008) Ann Hematol, 87, pp. 777-795Weinshilboum, R., Inheritance and drug response (2003) N Engl J Med, 348, pp. 529-537Barragan, E., Collado, M., Cervera, J., Martin, G., Bolufer, P., Roman, J., The GST deletions and NQO1*2 polymorphism confers interindividual variability of response to treatment in patients with acute myeloid leukemia (2007) Leuk Res, 31, pp. 947-953Yuan, Z.H., Liu, Q., Zhang, Y., Liu, H.X., Zhao, J., Zhu, P., CYP2B6 gene single nucleotide polymorphisms and leukemia susceptibility (2011) Ann Hematol, 90, pp. 293-299Berkoz, M., Yalin, S., Association of CYP2B6 G15631T polymorphism with acute leukemia susceptibility (2009) Leuk Res, 33, pp. 919-923Traver, R.D., Horikoshi, T., Danenberg, K.D., Stadlbauer, T.H., Danenberg, P.V., Ross, D., NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity (1992) Cancer Res, 52, pp. 797-802Lanciotti, M., Dufour, C., Corral, L., Di Michele, P., Pigullo, S., De Rossi, G., Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements (2005) Leukemia, 19, pp. 214-216Rao, D.N., Anuradha, C., Vishnupriya, S., Sailaja, K., Surekha, D., Raghunadharao, D., Association of an MDR1 gene (C3435T) polymorphism with acute leukemia in India (2010) Asian Pac J Cancer Prev, 11, pp. 1063-1066Penna, G., Allegra, A., Alonci, A., Aguennouz, M., Garufi, A., Cannavo, A., MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis (2010) Med OncolRollinson, S., Roddam, P., Kane, E., Roman, E., Cartwright, R., Jack, A., Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukaemia (2000) Carcinogenesis, 21, pp. 43-47Krajinovic, M., Labuda, D., Richer, C., Karimi, S., Sinnett, D., Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms (1999) Blood, 93, pp. 1496-1501Smith, M.T., Wang, Y., Kane, E., Rollinson, S., Wiemels, J.L., Roman, E., Low NAD(P)H:quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults (2001) Blood, 97, pp. 1422-1426Jamroziak, K., Mlynarski, W., Balcerczak, E., Mistygacz, M., Trelinska, J., Mirowski, M., Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia (2004) Eur J Haematol, 72, pp. 314-321Arruda, V.R., Lima, C.S., Grignoli, C.R., de Melo, M.B., Lorand-Metze, I., Alberto, F.L., Increased risk for acute myeloid leukaemia in individuals with glutathione S-transferase mu 1 (GSTM1) and theta 1 (GSTT1) gene defects (2001) Eur J Haematol, 66, pp. 383-388Wang, B., Jin, F., Xie, Y., Tang, Y., Kan, R., Zheng, C., Association analysis of NAD(P)H:quinone oxidoreductase gene 609C/T polymorphism with Alzheimer's disease (2006) Neurosci Lett, 409, pp. 179-181Rodrigues, F.F., Santos, R.E., Melo, M.B., Silva, M.A., Oliveira, A.L., Rozenowicz, R.L., Correlation of polymorphism C3435T of the MDR-1 gene and the response of primary chemotherapy in women with locally advanced breast cancer (2008) Genet Mol Res, 7, pp. 177-183Kim, R.B., Leake, B.F., Choo, E.F., Dresser, G.K., Kubba, S.V., Schwarz, U.I., Identification of functionally variant MDR1 alleles among European Americans and African Americans (2001) Clin Pharmacol Ther, 70, pp. 189-199Johnstone, R.W., Ruefli, A.A., Smyth, M.J., (2000) Trends Biochem Sci, 25, pp. 1-6. , Multiple physiological functions for multidrug transporter P-glycoprotein?Steven, J.P., (1992) Applied multivariate statistics for the social sciences, , Lawrence Erlbaum Associates, New Jerse